This study showed that FDX1 is more highly expressed in patients with AD carrying the APOE ε4/ε4 genotype, suggesting that FDX1 may interact with the APOE ε4/ε4 genotype, jointly affecting the progression of the disease. Here, APOE is linked to Alzheimer disease.